"Provides excellent advice to his clients, is proactive and pragmatic and also listens to the client's opinions and views. He is always available to us."
Chambers Europe 2023
"You won't find a harder working or more dedicated lawyer than him. He also has incredible depth of knowledge and judgement and if there is a path to success, he will find it."
Chambers Europe 2023
"He has deep knowledge of all aspects of competition law and, importantly, combines that knowledge with really impeccable judgement."
Chambers Global 2022
"If he’s working on a matter, it's going to go smoothly and we will get the best possible result."
Chambers Global 2022
"Héctor Armengod is an exceptional competition lawyer. His pragmatic approach gets the job done. He is always available for his clients and provides an outstanding service. He also surrounds himself with excellent associates. He is currently one of the best competition lawyers working on European competition law."
The Legal 500 EMEA 2022
Thought Leader – Competition
Who's Who Legal 2024
"Hector is a true leader in the market."
Who's Who Legal 2023
"He is described as ‘excellent to work with’. He focuses his superb practice on compliance matters in regulated industries such as healthcare and medical devices."
Who's Who Legal 2022
"He is an absolutely fantastic practitioner with extensive experience representing clients in merger control proceedings."
Who's Who Legal 2021
Profile
Héctor Armengod, Vice Chair of the Global Antitrust & Competition Practice, helps clients secure antitrust clearances for their transformational deals before regulators in the EU and globally.
Leveraging over two decades of experience, Héctor combines deep industry knowledge with a unique understanding of the global antitrust landscape to help clients navigate:
Merger control proceedings before the European Commission, and other antitrust regulators globally
European Commission cartel and Article 102 TFEU investigations
Complex licensing, joint venture, distribution, co-promotion, co-marketing, and co-operation agreements in the context of competition law
He regularly guides clients on their largest and most complex strategic mergers, which typically require merger clearances in the EU and in multiple jurisdictions globally. Héctor’s expertise cuts across sectors, with a particular focus on life sciences, media and entertainment, automotive, industrial, and consumer products, and business services.
Before joining Latham, Héctor worked as competition lawyer at another international law firm in Brussels and in the Brussels and Madrid offices of a Spanish law firm. He gained insight into the workings of the European Commission during an internship with the Competition Directorate General of the European Commission.
Experience
Héctor's experience includes representing:
Life Sciences
Abcam in its US$5.7 billion sale to Danaher
Nordic Capital in its sale of The Binding Site to Thermo Fisher
Cerner in its US$28.3 billion sale to Oracle
Siemens Healthineers in its US$16.4 billion acquisition of Varian Medical System (conditional Phase I EU clearance)
Syneos Health in its US$7.1 billion sale to a consortium of private investment firms
Integra in its acquisition of J&J’s Codman Neuro Division
Acino in its acquisition of Takeda’s EMEA primary care portfolio
Eli Lilly in its acquisitions of:
Novartis’ Animal Health Business
Janssen Pharmaceutical’s Animal Health Business
Certain animal health assets from Pfizer, which had to divested as a result of Pfizer’s merger with Wyeth
Archimed in the acquisition of Natus Medical
Actavis’ acquisition of Warner Chilcott
ERT in its merger with Bioclinica
ICU Medical in the acquisition of Pfizer's Hospira Infusion Systems business
Altaris Capital Partners in the sale of BK Medical to GE Healthcare
Entertainment and Media
Live Nation in its:
Acquisition of control over Altice Arena in Portugal
Acquisition of MCD (unconditional Phase II clearance in UK and conditional Phase II clearance in Ireland)
US$2.5 billion acquisition of Ticketmaster
Omnicom in its:
Acquisition of Flywheel Digital
Planned merger with Publicis
Industrial and Automotive
Novelis in its US$2.6 billion acquisition of rival Aleris (conditional Phase II clearance in the EU)
One Rock Capital in its US$2 billion acquisition of Constantia Flexibles
Tenneco in its US$7.1 billion sale to Apollo Global Management
GCP Applied Technologies in its US$2.3 billion sale to Saint-Gobain
Hyundai in the creation of its autonomous driving vehicle JV with APTIV
Nissan Motor in its acquisition of control over Mitsubishi Motors
Siemens in its acquisition of Dresser Rand (unconditional clearance in Phase II in the EU)
Veyance Technologies in its acquisition by Continental
Eaton in its acquisition of Cooper Industries
Consumer Products and Business Services
Aon in its planned US$30 billion acquisition of Willis Towers Watson (conditional Phase II clearance in EU)
Multinational luxury fashion company Tapestry in its planned US$8.5 billion acquisition of Capri Holdings, owner of luxury fashion brands Versace, Michael Kors, and Jimmy Choo
Authentic Brands Group in its acquisition of the Reebok, Boardriders, and Champion brands
Qualifications
Bar Qualification
Brussels Bar - E List
Spain (Abogado)
Education
LL.M. (European Union Law), Leiden Law School (Netherlands), 2000
In the leading competition publication’s annual review of the strongest antitrust practices around the globe, the firm dominated in every category, ranking second across all specialties.
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.